Superficial bladder cancer T1G3: the choice of treatment

被引：5
作者：
Borkowski, A [1 ]
机构：
[1] Med Univ, Dept Urol, PL-02005 Warsaw, Poland
来源：
BJU INTERNATIONAL | 2002年 / 89卷 / 06期
关键词：
D O I：
10.1046/j.1464-410X.2002.02696.x
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：623 / 627
页数：5
相关论文
共 45 条
[1]   Sequential bacillus Calmette-Guerin and epirubicin versus bacillus Calmette-Guerin alone for superficial bladder tumors: A randomized prospective study [J].
Ali-El-Dein, B ;
Nabeeh, A ;
Ismail, EH ;
Ghoneim, MA .
JOURNAL OF UROLOGY, 1999, 162 (02) :339-342
[2]   RADICAL CYSTECTOMY FOR STAGE-TA, STAGE-TIS AND STAGE-T1 TRANSITIONAL-CELL CARCINOMA OF THE BLADDER [J].
AMLING, CL ;
THRASHER, JB ;
FRAZIER, HA ;
DODGE, RK ;
ROBERTSON, JE ;
PAULSON, DF .
JOURNAL OF UROLOGY, 1994, 151 (01) :31-36
[3]   Transurethral resection and sequential chemo-immunoprophylaxis in primary T1G3 bladder cancer [J].
Bono, AV ;
Lovisolo, JA ;
Saredi, G .
EUROPEAN UROLOGY, 2000, 37 (04) :478-482
[4]  
BOSTWICK DG, 1992, J CELL BIOCHEM, P31
[5]   INTRAVESICAL BACILLUS CALMETTE-GUERIN THERAPY FOR INSITU TRANSITIONAL CELL-CARCINOMA INVOLVING THE PROSTATIC URETHRA [J].
BRETTON, PR ;
HERR, HW ;
WHITMORE, WF ;
BADALAMENT, RA ;
KIMMEL, M ;
PROVET, J ;
OETTGEN, HF ;
MELAMED, MR ;
FAIR, WR .
JOURNAL OF UROLOGY, 1989, 141 (04) :853-856
[6]  
Cheng L, 1999, CANCER, V86, P1035, DOI 10.1002/(SICI)1097-0142(19990915)86:6<1035::AID-CNCR20>3.0.CO
[7]  
2-D
[8]  
DEBERARDINIS E, 1997, J UROLOGY, V157, pA830
[9]  
DUTTA SC, 2000, J UROL S, V163, pA662
[10]  
DUTTA SC, 2000, J UROL S, V163, P148
12345